Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10011209 | 0.82 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL19347420 | 0.79 | ALDH1A1 (0.37) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL10010636 | 0.77 | CYP2C19 (0.38) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL10011205 | 0.76 | CYP2C19 (0.36) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL10012294 | 0.75 | TDP1 (0.36) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL10012423 | 0.71 | CYP2C19 (0.65) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL10010809 | 0.70 | CYP2C19 (0.44) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL12820432 | 0.69 | CPT2 (0.48) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL10011203 | 0.67 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRHMGCR | |
| SCHEMBL25634370 | 0.66 | TSHR (0.55) | CYP2C19HIF1ACYP2D6TSHRHMGCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9130244-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | SLC8A1, OR10J3, SLC8B1 | CYP2C19 3763/4885HIF1A 3982/4885CYP2D6 2905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.